NCT03778957 2026-04-15
EMERALD-1
AstraZeneca
Phase 3 Active not recruiting
AstraZeneca
AstraZeneca
AstraZeneca
AstraZeneca
Bristol-Myers Squibb
Tempest Therapeutics
Memorial Sloan Kettering Cancer Center
Can-Fite BioPharma
Tehran University of Medical Sciences